{
    "clinical_study": {
        "@rank": "77238", 
        "arm_group": {
            "arm_group_label": "Indigo Carmine", 
            "arm_group_type": "Experimental", 
            "description": "Indigo Carmine (2 mg per kilo) and 2nd half of PEG dose will be orally administered to patients prior to  colonoscopy."
        }, 
        "brief_summary": {
            "textblock": "The purpose of this study is to examine whether oral administration of Indigo Carmine\n      together with  Polyethylene Glycol (PEG), the usual  colon preparatory solution, can be used\n      instead of staining during the examination itself."
        }, 
        "brief_title": "Chromoendoscopy of the Colon After Oral Administration of Indigo Carmine", 
        "completion_date": {
            "#text": "December 2013", 
            "@type": "Anticipated"
        }, 
        "condition": "Inflammatory Bowel Diseases", 
        "condition_browse": {
            "mesh_term": [
                "Inflammatory Bowel Diseases", 
                "Intestinal Diseases"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Patients suffering from Inflammatory Bowel Disease\n\n          -  Patients under surveillance for Disease-Associated Lesions and Masses (DALM)\n\n        Exclusion Criteria:\n\n          -  All others"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "10", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "July 31, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01914445", 
            "org_study_id": "HYMC-46-13"
        }, 
        "intervention": {
            "arm_group_label": "Indigo Carmine", 
            "description": "Oral administration of Indigo Carmine prior to colonoscopy", 
            "intervention_name": "Indigo Carmine", 
            "intervention_type": "Drug", 
            "other_name": "FD&C Blue 2"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "July 31, 2013", 
        "location": {
            "facility": {
                "address": {
                    "city": "Hadera", 
                    "country": "Israel", 
                    "zip": "38100"
                }, 
                "name": "Hillel Yaffe Medical Center"
            }, 
            "investigator": {
                "last_name": "Vitaly Verzhbitsky, MD", 
                "role": "Principal Investigator"
            }, 
            "status": "Not yet recruiting"
        }, 
        "location_countries": {
            "country": "Israel"
        }, 
        "number_of_arms": "1", 
        "overall_contact": {
            "email": "vitalyv@hy.health.gov.il", 
            "last_name": "Vitaly Verzhbitsky, MD", 
            "phone": "972-505703554"
        }, 
        "overall_official": {
            "affiliation": "Hillel Yaffe Medical Center", 
            "last_name": "Vitaly Verzhbitsky, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Not yet recruiting", 
        "oversight_info": {
            "authority": "Israel: Ministry of Health", 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "December 2013", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "The efficacy of Indigo Carmine in staining tissues to better characterize, delineate, and highlight the gastrointestinal mucosa will be determined during the colonoscopic examination.  Biopsies will be taken from suspicious lesions.", 
            "measure": "Efficacy of Indigo Carmine during oral administration", 
            "safety_issue": "No", 
            "time_frame": "One hour"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01914445"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "Hillel Yaffe Medical Center", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Hillel Yaffe Medical Center", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "August 2013", 
        "study_design": "Allocation: Non-Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Diagnostic", 
        "study_type": "Interventional", 
        "verification_date": "July 2013"
    }
}